Differentiation-associated	O
expression	O
of	O
the	O
Epstein-Barr	B-protein
virus	I-protein
BZLF1	I-protein
transactivator	I-protein
protein	I-protein
in	O
oral	O
hairy	O
leukoplakia	O
.	O

The	O
BZLF1	B-protein
protein	I-protein
of	O
Epstein-Barr	O
virus	O
(	O
EBV	O
)	O
is	O
a	O
key	O
immediate-early	B-protein
protein	I-protein
which	O
has	O
been	O
shown	O
to	O
disrupt	O
virus	O
latency	O
in	O
EBV-infected	B-cell_type
B	I-cell_type
cells	I-cell_type
.	O

We	O
have	O
generated	O
a	O
monoclonal	B-protein
antibody	I-protein
,	O
BZ1	B-protein
,	O
to	O
BZLF1	B-protein
which	O
reacts	O
in	O
immunohistology	O
,	O
immunoblotting	O
,	O
and	O
immunoprecipitation	O
and	O
which	O
recognizes	O
both	O
the	O
active	B-protein
,	I-protein
dimeric	I-protein
form	I-protein
and	O
the	O
inactive	B-protein
,	I-protein
monomeric	I-protein
form	I-protein
of	O
the	O
protein	O
.	O

Biopsies	O
of	O
oral	O
hairy	O
leukoplakia	O
,	O
an	O
AIDS-associated	O
lesion	O
characterized	O
by	O
high-level	O
EBV	O
replication	O
,	O
were	O
examined	O
by	O
immunohistochemistry	O
using	O
the	O
BZ1	B-protein
monoclonal	B-protein
antibody	I-protein
.	O

A	O
differentiation-associated	O
pattern	O
of	O
BZLF1	B-protein
expression	O
was	O
observed	O
,	O
BZ1	B-protein
reacting	O
with	O
nuclei	O
of	O
the	O
upper	O
spinous	O
layer	O
of	O
the	O
lesion	O
.	O

This	O
finding	O
suggests	O
that	O
the	O
BZLF1	B-DNA
promoter	I-DNA
may	O
be	O
regulated	O
by	O
the	O
degree	O
of	O
squamous	O
differentiation	O
.	O

A	O
comparison	O
of	O
in	O
situ	O
hybridization	O
to	O
EBV	B-DNA
DNA	I-DNA
and	O
viral	B-protein
capsid	I-protein
antigen	I-protein
staining	O
with	O
BZ1	B-protein
reactivity	O
suggested	O
that	O
BZLF1	B-protein
expression	O
precedes	O
rampant	O
virus	O
replication	O
.	O

The	O
inability	O
to	O
detect	O
EBV	O
in	O
the	O
lower	O
epithelial	O
layers	O
of	O
oral	O
hairy	O
leukoplakia	O
raises	O
questions	O
concerning	O
the	O
nature	O
of	O
EBV	O
latency	O
and	O
persistence	O
in	O
stratified	O
squamous	O
epithelium	O
.	O

JournAL	NULL
or	NULL
ViRoLOGY	NULL
,	NULL
June	NULL
1991	NULL
,	NULL
p.	NULL
2868-2874	NULL
0022-538	NULL
X/91/062868-07	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
Â©	NULL
1991	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

65	NULL
,	NULL
No	NULL
.	NULL

6	NULL
Differentiation-Associated	NULL
Expression	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
Virus	NULL
BZLF1l	NULL
Transactivator	NULL
Protein	NULL
in	NULL
Oral	NULL
Hairy	NULL
Leukoplakia	NULL
L.	NULL
S.	NULL
YOUNG	NULL
,	NULL
``	NULL
*	NULL
R.	NULL
LAU	NULL
,	NULL
``	NULL
M.	NULL
ROWE	NULL
,	NULL
G.	NULL
NIEDOBITEK	NULL
,	NULL
``	NULL
G.	NULL
PACKHAM	NULL
,	NULL
*	NULL
F.	NULL
SHANAHAN	NULL
,	NULL
``	NULL
D.	NULL
T.	NULL
ROWE	NULL
,	NULL
``	NULL
D.	NULL
GREENSPAN	NULL
,	NULL
*	NULL
J.	NULL
S.	NULL
GREENSPAN	NULL
,	NULL
*	NULL
A	NULL
.	NULL

B.	NULL
RICKINSON	NULL
,	NULL
'	NULL
anp	NULL
P.	NULL
J.	NULL
FARRELL	NULL
Department	NULL
of	NULL
Cancer	NULL
Studies	NULL
,	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
Laboratories	NULL
,	NULL
The	NULL
Medical	NULL
School	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
,	NULL
P.O	NULL
.	NULL

Box	NULL
363	NULL
,	NULL
Birmingham	NULL
B15	NULL
2TT	NULL
,	NULL
'	NULL
and	NULL
Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
St.	NULL
Mary	NULL
's	NULL
Hospital	NULL
Medical	NULL
School	NULL
,	NULL
London	NULL
W2	NULL
IPG	NULL
,	NULL
``	NULL
United	NULL
Kingdom	NULL
,	NULL
and	NULL
Oral	NULL
AIDS	NULL
Center	NULL
and	NULL
Department	NULL
of	NULL
Stomatology	NULL
,	NULL
School	NULL
of	NULL
Dentistry	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
California	NULL
94143-0512	NULL
``	NULL
Received	NULL
6	NULL
December	NULL
1990/Accepted	NULL
7	NULL
February	NULL
1991	NULL
The	NULL
BZLF1	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
key	NULL
immediate-early	NULL
protein	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
disrupt	NULL
virus	NULL
latency	NULL
in	NULL
EBV-infected	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
generated	NULL
a	NULL
monoclonal	NULL
antibody	NULL
,	NULL
BZ1	NULL
,	NULL
to	NULL
BZLF1	NULL
which	NULL
reacts	NULL
in	NULL
immunohistology	NULL
,	NULL
immunoblotting	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
and	NULL
which	NULL
recognizes	NULL
both	NULL
the	NULL
active	NULL
,	NULL
dimeric	NULL
form	NULL
and	NULL
the	NULL
inactive	NULL
,	NULL
monomeric	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Biopsies	NULL
of	NULL
oral	NULL
hairy	NULL
leukoplakia	NULL
,	NULL
an	NULL
AIDS-associated	NULL
lesion	NULL
characterized	NULL
by	NULL
high-level	NULL
EBV	NULL
replication	NULL
,	NULL
were	NULL
examined	NULL
by	NULL
immunohistochemistry	NULL
using	NULL
the	NULL
BZ1	NULL
monoclonal	NULL
antibody	NULL
.	NULL

A	NULL
differentiation-associated	NULL
pattern	NULL
of	NULL
BZLF1	NULL
expression	NULL
was	NULL
observed	NULL
,	NULL
BZ1	NULL
reacting	NULL
with	NULL
nuclei	NULL
of	NULL
the	NULL
upper	NULL
spinous	NULL
layer	NULL
of	NULL
the	NULL
lesion	NULL
.	NULL

This	NULL
finding	NULL
suggests	NULL
that	NULL
the	NULL
BZLF1	NULL
promoter	NULL
may	NULL
be	NULL
regulated	NULL
by	NULL
the	NULL
degree	NULL
of	NULL
squamous	NULL
differentiation	NULL
.	NULL

A	NULL
comparison	NULL
of	NULL
in	NULL
situ	NULL
hybridization	NULL
to	NULL
EBV	NULL
DNA	NULL
and	NULL
viral	NULL
capsid	NULL
antigen	NULL
staining	NULL
with	NULL
BZ1	NULL
reactivity	NULL
suggested	NULL
that	NULL
BZLF1	NULL
expression	NULL
precedes	NULL
rampant	NULL
virus	NULL
replication	NULL
.	NULL

The	NULL
inability	NULL
to	NULL
detect	NULL
EBV	NULL
in	NULL
the	NULL
lower	NULL
epithelial	NULL
layers	NULL
of	NULL
oral	NULL
hairy	NULL
leukoplakia	NULL
raises	NULL
questions	NULL
concerning	NULL
the	NULL
nature	NULL
of	NULL
EBV	NULL
latency	NULL
and	NULL
persistence	NULL
in	NULL
stratified	NULL
squamous	NULL
epithelium	NULL
.	NULL

Oral	NULL
hairy	NULL
leukoplakia	NULL
(	NULL
OHL	NULL
)	NULL
is	NULL
a	NULL
recently	NULL
described	NULL
epithelial	NULL
lesion	NULL
occurring	NULL
in	NULL
association	NULL
with	NULL
AIDS	NULL
(	NULL
7	NULL
)	NULL
.	NULL

OHL	NULL
presents	NULL
as	NULL
raised	NULL
white	NULL
areas	NULL
usually	NULL
on	NULL
the	NULL
lateral	NULL
border	NULL
of	NULL
the	NULL
tongue	NULL
.	NULL

The	NULL
histological	NULL
appearance	NULL
is	NULL
characterized	NULL
by	NULL
an	NULL
intracellular	NULL
edema	NULL
of	NULL
spinous	NULL
cells	NULL
,	NULL
alterations	NULL
of	NULL
the	NULL
nuclei	NULL
such	NULL
as	NULL
basophilic	NULL
nuclear	NULL
inclusions	NULL
,	NULL
and	NULL
superficial	NULL
parakeratosis	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Although	NULL
this	NULL
histology	NULL
resembles	NULL
that	NULL
observed	NULL
in	NULL
papillomavirus-associated	NULL
infections	NULL
,	NULL
there	NULL
has	NULL
been	NULL
no	NULL
reliable	NULL
demonstration	NULL
of	NULL
such	NULL
an	NULL
infection	NULL
in	NULL
OHL	NULL
.	NULL

Initial	NULL
examination	NULL
of	NULL
OHL	NULL
under	NULL
the	NULL
electron	NULL
microscope	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
herpes-type	NULL
virus	NULL
particle	NULL
which	NULL
was	NULL
later	NULL
confirmed	NULL
as	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
both	NULL
by	NULL
DNA	NULL
hybridization	NULL
studies	NULL
and	NULL
by	NULL
immunohistochemical	NULL
analysis	NULL
with	NULL
antibodies	NULL
directed	NULL
against	NULL
EBV	NULL
antigens	NULL
of	NULL
the	NULL
virus	NULL
lytic	NULL
cycle	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
viral	NULL
capsid	NULL
antigen	NULL
(	NULL
VCA	NULL
)	NULL
and	NULL
early	NULL
antigen	NULL
(	NULL
EA-D	NULL
and	NULL
EA-R	NULL
)	NULL
(	NULL
8	NULL
)	NULL
.	NULL

On	NULL
treatment	NULL
with	NULL
acyclovir	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
herpesvirus	NULL
DNA	NULL
polymerase	NULL
,	NULL
OHL	NULL
was	NULL
found	NULL
to	NULL
regress	NULL
(	NULL
4	NULL
)	NULL
,	NULL
implicating	NULL
EBV	NULL
as	NULL
an	NULL
etiological	NULL
agent	NULL
in	NULL
the	NULL
development	NULL
of	NULL
this	NULL
nonmalignant	NULL
epithelial	NULL
proliferation	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
to	NULL
EBV	NULL
DNA	NULL
has	NULL
revealed	NULL
replicating	NULL
EBV	NULL
distributed	NULL
focally	NULL
in	NULL
the	NULL
more	NULL
differentiated	NULL
layers	NULL
of	NULL
OHL	NULL
(	NULL
2	NULL
,	NULL
11	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
pattern	NULL
of	NULL
immunostaining	NULL
observed	NULL
by	NULL
using	NULL
either	NULL
polyclonal	NULL
human	NULL
sera	NULL
to	NULL
late	NULL
viral	NULL
antigens	NULL
or	NULL
monoclonal	NULL
antibodies	NULL
(	NULL
MAbs	NULL
)	NULL
to	NULL
VCA	NULL
,	NULL
early	NULL
antigens	NULL
(	NULL
EA-D	NULL
and	NULL
EA-R	NULL
)	NULL
,	NULL
and	NULL
membrane	NULL
antigen	NULL
.	NULL

The	NULL
association	NULL
of	NULL
EBV	NULL
replication	NULL
with	NULL
the	NULL
terminally	NULL
differentiating	NULL
tongue	NULL
epithelial	NULL
cells	NULL
of	NULL
OHL	NULL
is	NULL
consistent	NULL
with	NULL
previous	NULL
studies	NULL
of	NULL
epithelial	NULL
EBV	NULL
infection	NULL
(	NULL
23	NULL
)	NULL
and	NULL
suggests	NULL
that	NULL
OHL	NULL
may	NULL
represent	NULL
an	NULL
exaggerated	NULL
form	NULL
of	NULL
the	NULL
natural	NULL
epithelial	NULL
cell	NULL
infection	NULL
with	NULL
EBV	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
have	NULL
generated	NULL
a	NULL
MAb	NULL
to	NULL
the	NULL
key	NULL
immediate-early	NULL
protein	NULL
BZLF1	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
disrupt	NULL
virus	NULL
latency	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
12	NULL
)	NULL
.	NULL

This	NULL
MAb	NULL
has	NULL
been	NULL
fully	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

2868	NULL
characterized	NULL
and	NULL
used	NULL
to	NULL
analyze	NULL
the	NULL
pattern	NULL
of	NULL
BZLF1	NULL
expression	NULL
in	NULL
OHL	NULL
.	NULL

We	NULL
demonstrate	NULL
,	NULL
for	NULL
the	NULL
first	NULL
time	NULL
,	NULL
the	NULL
differentiation-associated	NULL
expression	NULL
of	NULL
BZLFI	NULL
in	NULL
a	NULL
biologically	NULL
relevant	NULL
cellular	NULL
environment	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
human	NULL
epithelial	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Collection	NULL
of	NULL
OHL	NULL
biopsies	NULL
.	NULL

The	NULL
subjects	NULL
chosen	NULL
for	NULL
tongue	NULL
biopsies	NULL
were	NULL
individuals	NULL
with	NULL
symptomatic	NULL
human	NULL
immu-nodeficiency	NULL
virus	NULL
disease	NULL
(	NULL
CDC	NULL
IV	NULL
)	NULL
in	NULL
whom	NULL
OHL	NULL
had	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
3	NULL
months	NULL
.	NULL

Subjects	NULL
were	NULL
evaluated	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
OHL	NULL
by	NULL
two	NULL
physicians	NULL
before	NULL
being	NULL
submitted	NULL
to	NULL
tongue	NULL
biopsy	NULL
.	NULL

Under	NULL
local	NULL
anesthetic	NULL
,	NULL
an	NULL
elliptical	NULL
incisional	NULL
biopsy	NULL
(	NULL
2	NULL
mm	NULL
wide	NULL
by	NULL
3	NULL
mm	NULL
long	NULL
)	NULL
was	NULL
taken	NULL
from	NULL
the	NULL
side	NULL
of	NULL
the	NULL
tongue	NULL
with	NULL
OHL	NULL
.	NULL

The	NULL
tissue	NULL
sample	NULL
was	NULL
snap-frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
and	NULL
subsequently	NULL
stored	NULL
at	NULL
-70Â°C	NULL
.	NULL

Four	NULL
of	NULL
the	NULL
biopsies	NULL
analyzed	NULL
were	NULL
from	NULL
British	NULL
patients	NULL
,	NULL
and	NULL
two	NULL
biopsies	NULL
were	NULL
from	NULL
American	NULL
patients	NULL
.	NULL

Generation	NULL
of	NULL
MAbs	NULL
.	NULL

A	NULL
fusion	NULL
protein	NULL
containing	NULL
part	NULL
of	NULL
Staphylococcus	NULL
aureus	NULL
protein	NULL
A	NULL
at	NULL
its	NULL
N	NULL
terminus	NULL
joined	NULL
to	NULL
the	NULL
full-length	NULL
BZLF1	NULL
sequence	NULL
(	NULL
pREX-BZLF1	NULL
)	NULL
was	NULL
used	NULL
for	NULL
immunization	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Hybridomas	NULL
were	NULL
generated	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
19	NULL
)	NULL
,	NULL
and	NULL
culture	NULL
supernatants	NULL
were	NULL
screened	NULL
for	NULL
relevant	NULL
antibodies	NULL
by	NULL
using	NULL
an	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
with	NULL
a	NULL
different	NULL
fusion	NULL
protein	NULL
(	NULL
pEX-BZLF1	NULL
)	NULL
,	NULL
containing	NULL
part	NULL
of	NULL
the	NULL
CII	NULL
protein	NULL
of	NULL
phage	NULL
A	NULL
fused	NULL
to	NULL
BZLF1	NULL
,	NULL
as	NULL
the	NULL
positive	NULL
target	NULL
antigen	NULL
and	NULL
with	NULL
phage	NULL
lambda	NULL
control	NULL
protein	NULL
(	NULL
NpeX	NULL
)	NULL
as	NULL
an	NULL
irrelevant	NULL
target	NULL
antigen	NULL
(	NULL
17	NULL
)	NULL
.	NULL

The	NULL
hybridoma	NULL
cultures	NULL
that	NULL
produced	NULL
apparently	NULL
BZLF1	NULL
specific	NULL
antibodies	NULL
in	NULL
the	NULL
ELI-SAs	NULL
were	NULL
subsequently	NULL
tested	NULL
for	NULL
reactivity	NULL
on	NULL
virus-produc-tive	NULL
and	NULL
nonproductive	NULL
cell	NULL
lines	NULL
in	NULL
an	NULL
indirect	NULL
immunofluorescence	NULL
test	NULL
.	NULL

At	NULL
this	NULL
stage	NULL
,	NULL
hybridomas	NULL
of	NULL
interest	NULL
were	NULL
recloned	NULL
by	NULL
limiting	NULL
dilution	NULL
and	NULL
characterized	NULL
further	NULL
by	NULL
immunoblotting	NULL
experiments	NULL
.	NULL

In	NULL
this	NULL
way	NULL
an	NULL
immunoglobu-	NULL
Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
lin	NULL
(	NULL
Ig	NULL
)	NULL
G1	NULL
MAb	NULL
,	NULL
designated	NULL
BZ1	NULL
,	NULL
specific	NULL
for	NULL
BZLFI	NULL
was	NULL
isolated	NULL
.	NULL

Immunofluorescence	NULL
and	NULL
immunohistochemical	NULL
staining	NULL
of	NULL
cells	NULL
and	NULL
tissues	NULL
.	NULL

For	NULL
immunofluorescence	NULL
,	NULL
a	NULL
three-step	NULL
dou-ble-conjugate	NULL
indirect	NULL
method	NULL
was	NULL
used	NULL
.	NULL

Methanol-fixed	NULL
cell	NULL
spreads	NULL
or	NULL
cryostat	NULL
sections	NULL
were	NULL
rehydrated	NULL
with	NULL
phos-phate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
containing	NULL
20	NULL
%	NULL
normal	NULL
rabbit	NULL
serum	NULL
and	NULL
10	NULL
%	NULL
EBV-seronegative	NULL
human	NULL
serum	NULL
and	NULL
incubated	NULL
with	NULL
various	NULL
dilutions	NULL
of	NULL
hybridoma	NULL
culture	NULL
supernatant	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37Â°C	NULL
.	NULL

Bound	NULL
MAb	NULL
was	NULL
detected	NULL
by	NULL
incubation	NULL
with	NULL
fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG	NULL
(	NULL
Sigma	NULL
)	NULL
for	NULL
1.5	NULL
h	NULL
at	NULL
37Â°C	NULL
,	NULL
washing	NULL
in	NULL
PBS	NULL
,	NULL
and	NULL
then	NULL
incubation	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37Â°C	NULL
with	NULL
FITC-conjugated	NULL
rabbit	NULL
anti-goat	NULL
IgG	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
finally	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
mounted	NULL
in	NULL
DABCO	NULL
(	NULL
1,4-diazabicyclo	NULL
[	NULL
2,2,2Joctane	NULL
)	NULL
-based	NULL
antifading	NULL
mountant	NULL
,	NULL
and	NULL
visualized	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

For	NULL
double	NULL
staining	NULL
,	NULL
an	NULL
indirect	NULL
immunofluorescence	NULL
technique	NULL
was	NULL
used	NULL
.	NULL

This	NULL
procedure	NULL
relied	NULL
on	NULL
the	NULL
different	NULL
subclass	NULL
specificities	NULL
of	NULL
the	NULL
primary	NULL
MAbs	NULL
and	NULL
used	NULL
a	NULL
mixture	NULL
of	NULL
FITC-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgGl	NULL
and	NULL
rhodamine-conjugated	NULL
goat	NULL
anti-mouse	NULL
IgG2a	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
Associates	NULL
)	NULL
as	NULL
the	NULL
second	NULL
step	NULL
.	NULL

Immunohistology	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
alkaline	NULL
phosphatase-anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
)	NULL
technique	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
1	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
,	NULL
using	NULL
the	NULL
**S-labeled	NULL
plasmid	NULL
pBa-W	NULL
(	NULL
3.1-kb	NULL
BamHI-W	NULL
internal	NULL
repetitive	NULL
fragment	NULL
of	NULL
EBV	NULL
strain	NULL
M-ABA	NULL
,	NULL
subcloned	NULL
in	NULL
pBR322	NULL
)	NULL
kindly	NULL
provided	NULL
by	NULL
G.	NULL
W.	NULL
Bornkamm	NULL
,	NULL
Munich	NULL
,	NULL
Germany	NULL
(	NULL
16	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
frozen	NULL
sections	NULL
were	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
for	NULL
20	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
,	NULL
incubated	NULL
in	NULL
0.02	NULL
N	NULL
HCl	NULL
for	NULL
10	NULL
min	NULL
at	NULL
RT	NULL
,	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
a	NULL
proteolytic	NULL
digestion	NULL
in	NULL
0.125	NULL
mg	NULL
of	NULL
pronase	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
per	NULL
ml	NULL
for	NULL
10	NULL
min	NULL
at	NULL
RT	NULL
.	NULL

After	NULL
extensive	NULL
washing	NULL
in	NULL
PBS	NULL
,	NULL
25	NULL
pl	NULL
of	NULL
hybridization	NULL
mixture	NULL
containing	NULL
1	NULL
ng	NULL
of	NULL
the	NULL
labeled	NULL
probe	NULL
was	NULL
applied	NULL
to	NULL
a	NULL
section	NULL
.	NULL

Cell	NULL
and	NULL
probe	NULL
DNA	NULL
were	NULL
denatured	NULL
together	NULL
for	NULL
2	NULL
min	NULL
at	NULL
95Â°C	NULL
,	NULL
and	NULL
hybridization	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
37Â°C	NULL
.	NULL

Slides	NULL
were	NULL
then	NULL
washed	NULL
in	NULL
50	NULL
%	NULL
formamide-0.1x	NULL
SSC	NULL
(	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
sodium	NULL
citrate	NULL
)	NULL
-10	NULL
mM	NULL
dithiothreitol	NULL
for	NULL
4	NULL
h	NULL
,	NULL
rinsed	NULL
in	NULL
2	NULL
%	NULL
SSC	NULL
,	NULL
dehydrated	NULL
through	NULL
graded	NULL
ethanols	NULL
,	NULL
dipped	NULL
in	NULL
Ilford	NULL
GS	NULL
emulsion	NULL
,	NULL
exposed	NULL
at	NULL
4Â°C	NULL
,	NULL
developed	NULL
,	NULL
and	NULL
counter-stained	NULL
.	NULL

Double-labeling	NULL
immunohistology	NULL
and	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

For	NULL
the	NULL
simultaneous	NULL
detection	NULL
of	NULL
EBV	NULL
DNA	NULL
and	NULL
the	NULL
BZLF1	NULL
protein	NULL
in	NULL
the	NULL
same	NULL
tissue	NULL
section	NULL
,	NULL
frozen	NULL
sections	NULL
were	NULL
fixed	NULL
sequentially	NULL
in	NULL
acetone	NULL
and	NULL
chloroform	NULL
for	NULL
30	NULL
min	NULL
each	NULL
at	NULL
RT	NULL
.	NULL

Immunohistology	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
above	NULL
.	NULL

After	NULL
APAAP	NULL
staining	NULL
,	NULL
slides	NULL
were	NULL
subjected	NULL
to	NULL
in	NULL
situ	NULL
hybridization	NULL
without	NULL
any	NULL
additional	NULL
treatment	NULL
.	NULL

After	NULL
hybridization	NULL
overnight	NULL
and	NULL
washing	NULL
as	NULL
described	NULL
above	NULL
,	NULL
slides	NULL
were	NULL
air	NULL
dried	NULL
briefly	NULL
,	NULL
dipped	NULL
into	NULL
Ilford	NULL
GS	NULL
emulsion	NULL
,	NULL
and	NULL
exposed	NULL
for	NULL
3	NULL
days	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
then	NULL
developed	NULL
,	NULL
counterstained	NULL
with	NULL
hematoxylin	NULL
,	NULL
and	NULL
embedded	NULL
with	NULL
glycerol	NULL
gelatin	NULL
(	NULL
Dakopatts	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
.	NULL

SDS-PAGE	NULL
and	NULL
immunoblotting	NULL
.	NULL

Protein	NULL
extracts	NULL
of	NULL
appropriate	NULL
cell	NULL
lines	NULL
were	NULL
analyzed	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
PAGE	NULL
)	NULL
on	NULL
10	NULL
%	NULL
polyacylamide	NULL
Laemmli	NULL
gels	NULL
,	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
filters	NULL
,	NULL
probed	NULL
with	NULL
specific	NULL
antibodies	NULL
,	NULL
and	NULL
detected	NULL
with	NULL
*	NULL
``	NULL
I-protein	NULL
A	NULL
,	NULL
all	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Epitope	NULL
mapping	NULL
of	NULL
the	NULL
BZLF1-specific	NULL
MAb	NULL
.	NULL

Various	NULL
deletion	NULL
and	NULL
point	NULL
mutants	NULL
of	NULL
BZLF1	NULL
were	NULL
transcribed	NULL
and	NULL
translated	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
radioactive	NULL
protein	NULL
(	NULL
labeled	NULL
with	NULL
[	NULL
>	NULL
*SJcysteine	NULL
)	NULL
was	NULL
then	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
BZLF1	NULL
EXPRESSION	NULL
IN	NULL
ORAL	NULL
HAIRY	NULL
LEUKOPLAKIA	NULL
2869	NULL
BZLF1-specific	NULL
MAb	NULL
BZ1	NULL
,	NULL
and	NULL
30	NULL
wl	NULL
of	NULL
in	NULL
vitro	NULL
translation	NULL
reaction	NULL
mixture	NULL
was	NULL
mixed	NULL
with	NULL
25	NULL
wl	NULL
of	NULL
BZ1	NULL
culture	NULL
supernatant	NULL
and	NULL
220	NULL
pl	NULL
of	NULL
ELB	NULL
(	NULL
250	NULL
mM	NULL
NaCl	NULL
,	NULL
50	NULL
mM	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
[	NULL
HEPES	NULL
;	NULL
pH	NULL
7.01	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulfonyl	NULL
fluoride	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
0.1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
)	NULL
at	NULL
4Â°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Then	NULL
12.5	NULL
pl	NULL
of	NULL
a	NULL
1:1	NULL
slurry	NULL
of	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
that	NULL
had	NULL
been	NULL
precoated	NULL
with	NULL
a	NULL
rabbit	NULL
anti-mouse	NULL
Ig	NULL
antibody	NULL
(	NULL
Z259	NULL
;	NULL
Dakopatts	NULL
)	NULL
was	NULL
added	NULL
,	NULL
the	NULL
solution	NULL
was	NULL
mixed	NULL
for	NULL
30	NULL
min	NULL
at	NULL
4Â°C	NULL
,	NULL
and	NULL
the	NULL
beads	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
ELB	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
eluted	NULL
in	NULL
SDS-gel	NULL
sample	NULL
buffer	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
17.5	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
protein	NULL
A	NULL
beads	NULL
were	NULL
precoated	NULL
by	NULL
mixing	NULL
200	NULL
pl	NULL
of	NULL
a	NULL
1:1	NULL
slurry	NULL
of	NULL
beads	NULL
in	NULL
ELB	NULL
with	NULL
12	NULL
pl	NULL
7259	NULL
.	NULL

After	NULL
30	NULL
min	NULL
at	NULL
4Â°C	NULL
,	NULL
the	NULL
beads	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
in	NULL
ELB	NULL
.	NULL

Supershift	NULL
experiment	NULL
to	NULL
demonstrate	NULL
that	NULL
the	NULL
BZLFI-specific	NULL
MAb	NULL
recognizes	NULL
the	NULL
active	NULL
dimer	NULL
of	NULL
BZLF1I	NULL
.	NULL

Fusion	NULL
proteins	NULL
of	NULL
SmaI-C	NULL
BZLF1	NULL
cloned	NULL
at	NULL
the	NULL
BamHI-EcoRI	NULL
sites	NULL
of	NULL
pGEX	NULL
and	NULL
a	NULL
two-repeat	NULL
clone	NULL
of	NULL
the	NULL
EBNA-LP	NULL
(	NULL
as	NULL
a	NULL
control	NULL
)	NULL
were	NULL
induced	NULL
and	NULL
purified	NULL
by	NULL
chromatography	NULL
on	NULL
glutathione	NULL
agarose	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
each	NULL
fusion	NULL
protein	NULL
was	NULL
determined	NULL
by	NULL
estimating	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
Coomassie-stained	NULL
gel	NULL
band	NULL
on	NULL
a	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
comparison	NULL
with	NULL
known	NULL
amounts	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

Standard	NULL
gel	NULL
retardation	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Each	NULL
reaction	NULL
mixture	NULL
contained	NULL
6	NULL
ng	NULL
(	NULL
=0.5	NULL
pmol	NULL
)	NULL
of	NULL
**P-labeled	NULL
M	NULL
19-mer	NULL
(	NULL
double-stranded	NULL
GAAGCACTGACTCATGAAG	NULL
)	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
,	NULL
where	NULL
indicated	NULL
,	NULL
0.1	NULL
ug	NULL
(	NULL
=1	NULL
pmol	NULL
)	NULL
of	NULL
fusion	NULL
protein	NULL
,	NULL
1	NULL
wl	NULL
of	NULL
BZ1	NULL
ascites	NULL
fluid	NULL
,	NULL
or	NULL
1	NULL
wl	NULL
of	NULL
PE2	NULL
(	NULL
a	NULL
MAb	NULL
to	NULL
EBNA2	NULL
;	NULL
22	NULL
)	NULL
ascites	NULL
fluid	NULL
.	NULL

The	NULL
fusion	NULL
protein	NULL
was	NULL
allowed	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
radioactive	NULL
DNA	NULL
for	NULL
20	NULL
min	NULL
at	NULL
RT	NULL
prior	NULL
to	NULL
addition	NULL
of	NULL
the	NULL
appropriate	NULL
antibody	NULL
and	NULL
incubation	NULL
for	NULL
a	NULL
further	NULL
20	NULL
min	NULL
.	NULL

Controls	NULL
were	NULL
incubated	NULL
for	NULL
the	NULL
same	NULL
length	NULL
of	NULL
time	NULL
.	NULL

Complexes	NULL
were	NULL
resolved	NULL
by	NULL
gel	NULL
electrophoresis	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
and	NULL
were	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Characterization	NULL
of	NULL
the	NULL
BZLFI-specific	NULL
MAb	NULL
(	NULL
BZ1	NULL
)	NULL
.	NULL

An	NULL
IgG1	NULL
hybridoma	NULL
(	NULL
designated	NULL
BZ1	NULL
)	NULL
was	NULL
isolated	NULL
which	NULL
stably	NULL
produced	NULL
antibody	NULL
specifically	NULL
reactive	NULL
against	NULL
productively	NULL
infected	NULL
EBV	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
assessed	NULL
in	NULL
immunofluorescence	NULL
staining	NULL
.	NULL

This	NULL
MAb	NULL
reacted	NULL
strongly	NULL
in	NULL
immunoblotting	NULL
with	NULL
the	NULL
B95.8	NULL
and	NULL
P3HR1	NULL
producer	NULL
cell	NULL
lines	NULL
but	NULL
not	NULL
with	NULL
cell	NULL
lines	NULL
in	NULL
which	NULL
EBV	NULL
is	NULL
latent	NULL
(	NULL
i.e	NULL
.	NULL

,	NULL
X50-7	NULL
and	NULL
Raji	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
no	NULL
reactivity	NULL
was	NULL
observed	NULL
in	NULL
EBV-negative	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
major	NULL
protein	NULL
recognized	NULL
by	NULL
BZ1	NULL
in	NULL
B95.8	NULL
migrated	NULL
with	NULL
an	NULL
M	NULL
,	NULL
of	NULL
about	NULL
39,000	NULL
,	NULL
whereas	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
P3HR1	NULL
cell	NULL
line	NULL
migrated	NULL
with	NULL
an	NULL
M	NULL
,	NULL
of	NULL
approximately	NULL
42,000	NULL
.	NULL

This	NULL
result	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
using	NULL
either	NULL
polyclonal	NULL
human	NULL
sera	NULL
or	NULL
a	NULL
rabbit	NULL
monospecific	NULL
antiserum	NULL
(	NULL
17	NULL
,	NULL
18	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
BZl1	NULL
was	NULL
further	NULL
demonstrated	NULL
by	NULL
the	NULL
reactivity	NULL
of	NULL
the	NULL
MAb	NULL
with	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
BZLF1	NULL
cDNA	NULL
and	NULL
not	NULL
with	NULL
control	NULL
transfectants	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

To	NULL
map	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
BZ1	NULL
,	NULL
we	NULL
used	NULL
a	NULL
range	NULL
of	NULL
BZLF1	NULL
deletion	NULL
mutants	NULL
(	NULL
Fig	NULL
.	NULL

2a	NULL
)	NULL
cloned	NULL
into	NULL
the	NULL
transcription	NULL
vector	NULL
SP64	NULL
.	NULL

When	NULL
linearized	NULL
and	NULL
transcribed	NULL
with	NULL
SP6	NULL
polymerase	NULL
,	NULL
RNA	NULL
was	NULL
produced	NULL
which	NULL
yielded	NULL
BZLF1l	NULL
proteins	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
when	NULL
translated	NULL
in	NULL
the	NULL
reticu-locyte	NULL
lysate	NULL
(	NULL
Fig	NULL
.	NULL

2b	NULL
)	NULL
.	NULL

MAb	NULL
BZ1	NULL
was	NULL
then	NULL
used	NULL
in	NULL
immuno-precipitations	NULL
of	NULL
these	NULL
proteins	NULL
in	NULL
vitro	NULL
translated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
*S	NULL
}	NULL
cysteine	NULL
.	NULL

Whereas	NULL
the	NULL
N-Pstl	NULL
deletion	NULL
2870	NULL
YOUNG	NULL
ET	NULL
AL	NULL
.	NULL

B95.8	NULL
X50-7	NULL
P3HR1	NULL
Raji	NULL
BL40	NULL
293	NULL
+	NULL
BZ	NULL
293	NULL
+	NULL
pUC	NULL
116	NULL
97	NULL
66	NULL
45	NULL
29	NULL
20	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Immunoblot	NULL
showing	NULL
the	NULL
reactivity	NULL
and	NULL
specificity	NULL
of	NULL
MAb	NULL
BZ1	NULL
with	NULL
BZLF1	NULL
protein	NULL
in	NULL
productively	NULL
infected	NULL
cell	NULL
lines	NULL
(	NULL
B95.8	NULL
and	NULL
P3HR1	NULL
)	NULL
and	NULL
BZLF1	NULL
transfectants	NULL
(	NULL
293	NULL
+	NULL
BZ	NULL
)	NULL
.	NULL

No	NULL
reactivity	NULL
was	NULL
observed	NULL
with	NULL
EBV-positive	NULL
latently	NULL
infected	NULL
EBV-positive	NULL
lines	NULL
(	NULL
X50-7	NULL
and	NULL
Raji	NULL
)	NULL
,	NULL
an	NULL
EBV-negative	NULL
line	NULL
(	NULL
BL4O0	NULL
)	NULL
,	NULL
or	NULL
control	NULL
transfectants	NULL
(	NULL
293	NULL
+	NULL
pUC	NULL
)	NULL
.	NULL

mutant	NULL
of	NULL
BZLFI1	NULL
failed	NULL
to	NULL
be	NULL
recognized	NULL
by	NULL
BZ1	NULL
,	NULL
all	NULL
of	NULL
the	NULL
other	NULL
deletion	NULL
mutants	NULL
were	NULL
readily	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

2Â¢	NULL
and	NULL
d	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
suggested	NULL
that	NULL
the	NULL
epitope	NULL
recognized	NULL
by	NULL
BZ1	NULL
resided	NULL
in	NULL
the	NULL
dimerization	NULL
domain	NULL
of	NULL
BZLF1	NULL
.	NULL

Point	NULL
muta-	NULL
a	NULL
ford	NULL
b	NULL
N	NULL
-	NULL
Hincll	NULL
Hindill	NULL
delta	NULL
J	NULL
;	NULL
â	NULL
46	NULL
N	NULL
30	NULL
8	NULL
de	NULL
/\	NULL
21	NULL
14	NULL
DNA	NULL
binding	NULL
domain	NULL
Dimerisation	NULL
domain	NULL
<	NULL
--	NULL
Â»	NULL
7	NULL
ued	NULL
Lit	NULL
d	NULL
Point	NULL
mutants	NULL
x	NULL
BL	NULL
M	NULL
c	NULL
S	NULL
$	NULL
c	NULL
w	NULL
C	NULL
z	NULL
o	NULL
5	NULL
<	NULL
=	NULL
n	NULL
Â»	NULL
C	NULL
=	NULL
a	NULL
&	NULL
=	NULL
a	NULL
.	NULL

5~	NULL
4-4	NULL
:	NULL
8B	NULL
Â©	NULL
N	NULL
=	NULL
w	NULL
E	NULL
2	NULL
a	NULL
I	NULL
=	NULL
Ut	NULL
.	NULL

-	NULL
%	NULL
46	NULL
.	NULL

#	NULL
#	NULL
30	NULL
21	NULL
14	NULL
v4	NULL
#	NULL
%	NULL
Â©	NULL
7	NULL
J.	NULL
Viror	NULL
.	NULL

tions	NULL
within	NULL
the	NULL
dimerization	NULL
region	NULL
did	NULL
not	NULL
affect	NULL
BZ1l	NULL
recognition	NULL
.	NULL

The	NULL
M	NULL
point	NULL
mutant	NULL
was	NULL
immunoprecipitated	NULL
efficiently	NULL
in	NULL
two	NULL
such	NULL
experiments	NULL
(	NULL
one	NULL
illustrated	NULL
Fig	NULL
.	NULL

2Â¢	NULL
)	NULL
,	NULL
even	NULL
though	NULL
its	NULL
precipitation	NULL
seems	NULL
to	NULL
be	NULL
reduced	NULL
in	NULL
Fig	NULL
.	NULL

2d	NULL
.	NULL

The	NULL
KL	NULL
mutant	NULL
is	NULL
unable	NULL
to	NULL
dimerize	NULL
under	NULL
these	NULL
conditions	NULL
(	NULL
9	NULL
)	NULL
,	NULL
so	NULL
the	NULL
reactivity	NULL
of	NULL
BZ1	NULL
with	NULL
the	NULL
dimerization	NULL
domain	NULL
of	NULL
BZLFl	NULL
and	NULL
the	NULL
efficient	NULL
recognition	NULL
of	NULL
these	NULL
mutants	NULL
raised	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
this	NULL
MAb	NULL
would	NULL
recognize	NULL
the	NULL
dimerized	NULL
,	NULL
functional	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
(	NULL
10	NULL
)	NULL
or	NULL
might	NULL
be	NULL
reacting	NULL
only	NULL
with	NULL
the	NULL
inactive	NULL
,	NULL
monomeric	NULL
form	NULL
.	NULL

To	NULL
examine	NULL
this	NULL
point	NULL
,	NULL
gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
using	NULL
the	NULL
AP-1	NULL
site	NULL
upstream	NULL
of	NULL
BMLF1	NULL
as	NULL
the	NULL
target	NULL
and	NULL
glutathione	NULL
S-transferase	NULL
(	NULL
GST	NULL
)	NULL
fusion	NULL
proteins	NULL
of	NULL
either	NULL
BZLF1	NULL
(	NULL
GST-SmaI-C	NULL
)	NULL
or	NULL
,	NULL
as	NULL
a	NULL
control	NULL
,	NULL
EBNA-LP	NULL
(	NULL
GST-LP	NULL
)	NULL
.	NULL

These	NULL
assays	NULL
demonstrated	NULL
specific	NULL
binding	NULL
of	NULL
GST-SmaI-C	NULL
to	NULL
the	NULL
AP-1	NULL
site	NULL
,	NULL
as	NULL
shown	NULL
previously	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
tracks	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
MAb	NULL
BZ1	NULL
to	NULL
the	NULL
gel	NULL
retardation	NULL
assay	NULL
shifted	NULL
the	NULL
BZLFI-DNA	NULL
complex	NULL
(	NULL
track	NULL
8	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
MAb	NULL
was	NULL
able	NULL
to	NULL
recognize	NULL
the	NULL
functional	NULL
active	NULL
dimerized	NULL
form	NULL
of	NULL
the	NULL
BZLF1	NULL
protein	NULL
.	NULL

No	NULL
effect	NULL
was	NULL
observed	NULL
with	NULL
use	NULL
of	NULL
a	NULL
MAb	NULL
against	NULL
the	NULL
EBNA2Z	NULL
protein	NULL
(	NULL
track	NULL
9	NULL
)	NULL
,	NULL
and	NULL
no	NULL
shift	NULL
was	NULL
seen	NULL
with	NULL
the	NULL
GST-LP	NULL
fusion	NULL
protein	NULL
(	NULL
tracks	NULL
4	NULL
to	NULL
6	NULL
)	NULL
.	NULL

Reactivity	NULL
of	NULL
BZ1	NULL
with	NULL
OHL	NULL
biopsies	NULL
.	NULL

The	NULL
OHL	NULL
biopsy	NULL
material	NULL
was	NULL
initially	NULL
screened	NULL
for	NULL
EBV	NULL
infection	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
to	NULL
viral	NULL
DNA	NULL
and	NULL
by	NULL
immunostaining	NULL
for	NULL
VCA	NULL
.	NULL

Six	NULL
biopsies	NULL
were	NULL
selected	NULL
for	NULL
subsequent	NULL
analysis	NULL
.	NULL

Serial	NULL
sections	NULL
were	NULL
then	NULL
analyzed	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
stained	NULL
with	NULL
MAb	NULL
BZ1	NULL
and	NULL
the	NULL
anti-VCA	NULL
MAb	NULL
V3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
situ	NULL
hybridization	NULL
with	NULL
an	NULL
EBV-specific	NULL
probe	NULL
resulted	NULL
in	NULL
&	NULL
Â§	NULL
Â©	NULL
3âD	NULL
*	NULL
Â§	NULL
wo	NULL
_	NULL
Â©	NULL
va	NULL
â¬	NULL
am	NULL
3	NULL
9	NULL
o	NULL
-o	NULL
=o	NULL
#	NULL
a	NULL
f	NULL
Â§	NULL
%	NULL
roos	NULL
I	NULL
&	NULL
Â«	NULL
.	NULL

g	NULL
NEL	NULL
SaM	NULL
RO	NULL
-	NULL
(	NULL
0	NULL
%	NULL
106	NULL
RN	NULL
-	NULL
&	NULL
w	NULL
w	NULL
0	NULL
_	NULL
Â£	NULL
(	NULL
f	NULL
ve	NULL
K	NULL
=r	NULL
o	NULL
Â¥	NULL
's	NULL
``	NULL
k	NULL
&	NULL
8	NULL
o	NULL
)	NULL
$	NULL
-	NULL
=z	NULL
-Z	NULL
â¬	NULL
a	NULL
3	NULL
C	NULL
&	NULL
0	NULL
.	NULL

5	NULL
&	NULL
I*	NULL
&	NULL
.	NULL

ao	NULL
Ro	NULL
.	NULL

(	NULL
6	NULL
.n	NULL
oe	NULL
Ao	NULL
Â£	NULL
w	NULL
#	NULL
00	NULL
au.k	NULL
.d	NULL
.	NULL

Cx	NULL
cu	NULL
.	NULL

FIG	NULL
.	NULL

2	NULL
.	NULL

Epitope	NULL
mapping	NULL
of	NULL
MAb	NULL
BZ1	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Diagrammatic	NULL
representation	NULL
of	NULL
the	NULL
various	NULL
deletion	NULL
and	NULL
point	NULL
mutations	NULL
used	NULL
;	NULL
(	NULL
b	NULL
)	NULL
in	NULL
vitro	NULL
translations	NULL
without	NULL
immunoprecipitation	NULL
;	NULL
(	NULL
c	NULL
and	NULL
d	NULL
)	NULL
two	NULL
experiments	NULL
with	NULL
immunoprecipitation	NULL
.	NULL

Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Supershift	NULL
experiment	NULL
demonstrating	NULL
that	NULL
MAb	NULL
BZ1	NULL
recognizes	NULL
the	NULL
active	NULL
dimer	NULL
of	NULL
BZLF1	NULL
.	NULL

The	NULL
gel	NULL
retardation	NULL
reactions	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
2	NULL
)	NULL
,	NULL
using	NULL
the	NULL
AP-1	NULL
site	NULL
upstream	NULL
of	NULL
BMLF1	NULL
as	NULL
the	NULL
target	NULL
.	NULL

Tracks	NULL
:	NULL
1	NULL
to	NULL
3	NULL
,	NULL
reaction	NULL
mixtures	NULL
containing	NULL
no	NULL
fusion	NULL
protein	NULL
;	NULL
4	NULL
to	NULL
6	NULL
,	NULL
reaction	NULL
mixtures	NULL
containing	NULL
EBNA-LP	NULL
(	NULL
2R	NULL
)	NULL
fusion	NULL
protein	NULL
;	NULL
7	NULL
to	NULL
9	NULL
,	NULL
reaction	NULL
mixtures	NULL
containing	NULL
BZLF1	NULL
Smal-C	NULL
fusion	NULL
protein	NULL
;	NULL
2	NULL
,	NULL
5	NULL
,	NULL
and	NULL
8	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
MAb	NULL
BZ1	NULL
;	NULL
3	NULL
,	NULL
6	NULL
,	NULL
and	NULL
9	NULL
,	NULL
incubated	NULL
with	NULL
the	NULL
EBNA2-specific	NULL
MAb	NULL
,	NULL
PEZ	NULL
.	NULL

an	NULL
accumulation	NULL
of	NULL
grains	NULL
over	NULL
nuclei	NULL
of	NULL
the	NULL
upper	NULL
layers	NULL
of	NULL
the	NULL
epithelium	NULL
(	NULL
Fig	NULL
.	NULL

4a	NULL
)	NULL
.	NULL

This	NULL
signal	NULL
was	NULL
usually	NULL
very	NULL
in-tense	NULL
,	NULL
leading	NULL
to	NULL
saturation	NULL
of	NULL
the	NULL
emulsion	NULL
even	NULL
after	NULL
short	NULL
exposure	NULL
times	NULL
(	NULL
2	NULL
to	NULL
3	NULL
days	NULL
)	NULL
.	NULL

Several	NULL
clusters	NULL
of	NULL
positive	NULL
cells	NULL
separated	NULL
by	NULL
apparently	NULL
noninfected	NULL
cells	NULL
were	NULL
identified	NULL
in	NULL
each	NULL
specimen	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
focal	NULL
distribution	NULL
of	NULL
EBV	NULL
replication	NULL
.	NULL

Occasional	NULL
cells	NULL
adjacent	NULL
to	NULL
foci	NULL
of	NULL
viral	NULL
replication	NULL
displayed	NULL
a	NULL
weaker	NULL
signal	NULL
.	NULL

No	NULL
signal	NULL
was	NULL
observed	NULL
over	NULL
the	NULL
basal	NULL
cell	NULL
layers	NULL
,	NULL
and	NULL
no	NULL
signal	NULL
was	NULL
obtained	NULL
with	NULL
unrelated	NULL
probes	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
reactivity	NULL
of	NULL
both	NULL
MAb	NULL
BZ1	NULL
and	NULL
V3	NULL
was	NULL
consistent	NULL
with	NULL
this	NULL
pattern	NULL
of	NULL
viral	NULL
replication	NULL
.	NULL

Immunohistology	NULL
with	NULL
BZ1	NULL
MAb	NULL
produced	NULL
an	NULL
intense	NULL
staining	NULL
of	NULL
nuclei	NULL
in	NULL
the	NULL
upper	NULL
layers	NULL
of	NULL
OHL	NULL
epithelium	NULL
(	NULL
Fig	NULL
.	NULL

4b	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
stratum	NULL
corneum	NULL
demonstrated	NULL
a	NULL
markedly	NULL
reduced	NULL
level	NULL
of	NULL
EBV	NULL
replication	NULL
as	NULL
assessed	NULL
by	NULL
all	NULL
three	NULL
criteria	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
situ	NULL
hybridization	NULL
,	NULL
BZ1	NULL
staining	NULL
,	NULL
and	NULL
V3	NULL
staining	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
relative	NULL
association	NULL
of	NULL
BZLF1	NULL
and	NULL
VCA	NULL
expression	NULL
,	NULL
double	NULL
immunofluorescence	NULL
staining	NULL
was	NULL
per-formed	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
colocalization	NULL
of	NULL
BZLF1	NULL
and	NULL
VCA	NULL
proteins	NULL
was	NULL
observed	NULL
in	NULL
certain	NULL
cell	NULL
layers	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
population	NULL
of	NULL
cells	NULL
that	NULL
were	NULL
BZLF1	NULL
positive	NULL
but	NULL
VCA	NULL
negative	NULL
were	NULL
also	NULL
observed	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
present	NULL
in	NULL
the	NULL
upper	NULL
spinous	NULL
layer	NULL
and	NULL
generally	NULL
appeared	NULL
as	NULL
a	NULL
single	NULL
cell	NULL
layer	NULL
immediately	NULL
preceding	NULL
VCA	NULL
expression	NULL
.	NULL

This	NULL
observation	NULL
was	NULL
confirmed	NULL
in	NULL
experiments	NULL
in	NULL
which	NULL
sections	NULL
of	NULL
OHL	NULL
were	NULL
stained	NULL
with	NULL
MAb	NULL
BZ1	NULL
and	NULL
then	NULL
hybridized	NULL
for	NULL
EBV	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

4Â¢c	NULL
and	NULL
d	NULL
)	NULL
.	NULL

This	NULL
approach	NULL
permits	NULL
localization	NULL
of	NULL
antigen	NULL
and	NULL
viral	NULL
DNA	NULL
on	NULL
a	NULL
single	NULL
section	NULL
.	NULL

A	NULL
layer	NULL
of	NULL
BZLF1l-positive	NULL
cells	NULL
displaying	NULL
a	NULL
weak	NULL
EBV-specific	NULL
signal	NULL
was	NULL
observed	NULL
below	NULL
cell	NULL
layers	NULL
in	NULL
which	NULL
the	NULL
strong	NULL
signal	NULL
generated	NULL
by	NULL
high	NULL
levels	NULL
of	NULL
virus	NULL
DNA	NULL
obscured	NULL
BZ1	NULL
staining	NULL
.	NULL

No	NULL
BZ1	NULL
staining	NULL
was	NULL
observed	NULL
lower	NULL
in	NULL
the	NULL
epithelium	NULL
.	NULL

DISCUSSION	NULL
We	NULL
have	NULL
generated	NULL
a	NULL
specific	NULL
MAb	NULL
,	NULL
BZ1	NULL
,	NULL
against	NULL
the	NULL
BZLF1	NULL
protein	NULL
which	NULL
reacts	NULL
in	NULL
immunohistology	NULL
,	NULL
immunoblotting	NULL
,	NULL
and	NULL
immunoprecipitation	NULL
assays	NULL
.	NULL

Apart	NULL
from	NULL
the	NULL
usefulness	NULL
of	NULL
BZ1	NULL
in	NULL
the	NULL
analysis	NULL
of	NULL
BZLF1	NULL
expression	NULL
in	NULL
cells	NULL
and	NULL
tissues	NULL
,	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
reagent	NULL
to	NULL
recognize	NULL
the	NULL
BZLF1	NULL
EXPRESSION	NULL
IN	NULL
ORAL	NULL
HAIRY	NULL
LEUKOPLAKIA	NULL
2871	NULL
active	NULL
,	NULL
dimeric	NULL
form	NULL
of	NULL
the	NULL
BZLF1	NULL
protein	NULL
suggests	NULL
that	NULL
it	NULL
will	NULL
also	NULL
be	NULL
important	NULL
in	NULL
functional	NULL
studies	NULL
.	NULL

Epitope	NULL
mapping	NULL
experiments	NULL
localized	NULL
the	NULL
region	NULL
of	NULL
BZLFl	NULL
recognized	NULL
by	NULL
BZ1	NULL
to	NULL
the	NULL
dimerization	NULL
domain	NULL
.	NULL

Supershift	NULL
assays	NULL
clearly	NULL
demonstrated	NULL
that	NULL
BZ1	NULL
recognized	NULL
the	NULL
functional	NULL
dimerized	NULL
form	NULL
of	NULL
BZLF1	NULL
.	NULL

However	NULL
,	NULL
point	NULL
mutations	NULL
which	NULL
prevent	NULL
the	NULL
homodimerization	NULL
of	NULL
BZLFI1	NULL
did	NULL
not	NULL
prevent	NULL
recognition	NULL
of	NULL
the	NULL
protein	NULL
by	NULL
BZ1	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
MAb	NULL
reacts	NULL
with	NULL
both	NULL
the	NULL
active	NULL
,	NULL
dimeric	NULL
form	NULL
and	NULL
the	NULL
inactive	NULL
,	NULL
monomeric	NULL
form	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

Thus	NULL
,	NULL
BZ1	NULL
must	NULL
recognize	NULL
either	NULL
(	NULL
i	NULL
)	NULL
an	NULL
epitope	NULL
within	NULL
the	NULL
dimerization	NULL
domain	NULL
which	NULL
does	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
functional	NULL
dimerization	NULL
of	NULL
BZLF1	NULL
or	NULL
(	NULL
ii	NULL
)	NULL
an	NULL
epitope	NULL
outside	NULL
of	NULL
the	NULL
core	NULL
dimerization	NULL
domain	NULL
.	NULL

These	NULL
possibilities	NULL
are	NULL
currently	NULL
being	NULL
investigated	NULL
by	NULL
using	NULL
other	NULL
mutants	NULL
of	NULL
BZLF1	NULL
.	NULL

The	NULL
reactivity	NULL
of	NULL
BZ1	NULL
with	NULL
nuclei	NULL
of	NULL
the	NULL
upper	NULL
spinous	NULL
layer	NULL
of	NULL
OHL	NULL
confirms	NULL
previous	NULL
studies	NULL
demonstrating	NULL
a	NULL
differentiation-associated	NULL
pattern	NULL
of	NULL
EBV	NULL
replication	NULL
in	NULL
this	NULL
lesion	NULL
(	NULL
11	NULL
,	NULL
23	NULL
)	NULL
.	NULL

The	NULL
influence	NULL
of	NULL
squamous	NULL
differentiation	NULL
on	NULL
BZLF1l	NULL
expression	NULL
may	NULL
be	NULL
controlled	NULL
at	NULL
the	NULL
BZLF1	NULL
promoter	NULL
level	NULL
by	NULL
differentiation-associated	NULL
regulatory	NULL
factors	NULL
.	NULL

BZLF1	NULL
appears	NULL
to	NULL
be	NULL
expressed	NULL
prior	NULL
to	NULL
rampant	NULL
virus	NULL
replication	NULL
,	NULL
as	NULL
assessed	NULL
either	NULL
by	NULL
double	NULL
staining	NULL
for	NULL
BZLF1	NULL
and	NULL
VCA	NULL
or	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
BZLF1	NULL
staining	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
superficial	NULL
parakeratotic	NULL
layer	NULL
appears	NULL
to	NULL
have	NULL
a	NULL
markedly	NULL
reduced	NULL
level	NULL
of	NULL
both	NULL
BZLF1l	NULL
expression	NULL
and	NULL
viral	NULL
DNA	NULL
.	NULL

This	NULL
probably	NULL
results	NULL
from	NULL
the	NULL
reduced	NULL
availability	NULL
of	NULL
viral	NULL
antigens	NULL
and	NULL
DNA	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
this	NULL
hyperparakeratotic	NULL
layer	NULL
,	NULL
since	NULL
other	NULL
antigens	NULL
,	NULL
such	NULL
as	NULL
cy-tokeratins	NULL
,	NULL
are	NULL
also	NULL
less	NULL
efficiently	NULL
demonstrated	NULL
at	NULL
this	NULL
site	NULL
(	NULL
15	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
EBV	NULL
replication	NULL
may	NULL
be	NULL
down-regulated	NULL
at	NULL
the	NULL
terminal	NULL
stages	NULL
of	NULL
epithelial	NULL
differentiation	NULL
.	NULL

This	NULL
may	NULL
have	NULL
implications	NULL
for	NULL
the	NULL
amount	NULL
of	NULL
mature	NULL
virus	NULL
shed	NULL
from	NULL
OHL	NULL
.	NULL

The	NULL
replication	NULL
of	NULL
EBV	NULL
in	NULL
OHL	NULL
,	NULL
and	NULL
by	NULL
implication	NULL
probably	NULL
in	NULL
normal	NULL
epithelium	NULL
,	NULL
is	NULL
not	NULL
typical	NULL
of	NULL
herpesvi-ruses	NULL
.	NULL

Replication	NULL
of	NULL
herpesviruses	NULL
is	NULL
usually	NULL
accompanied	NULL
by	NULL
extensive	NULL
damage	NULL
to	NULL
the	NULL
affected	NULL
tissue	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
ulcers	NULL
in	NULL
herpes	NULL
simplex	NULL
virus-induced	NULL
stomatitis	NULL
or	NULL
intestinal	NULL
ulcers	NULL
caused	NULL
by	NULL
cytomegalovirus	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
EBV	NULL
replication	NULL
in	NULL
the	NULL
epithelial	NULL
cells	NULL
of	NULL
OHL	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
ulceration	NULL
.	NULL

Although	NULL
some	NULL
morphological	NULL
alterations	NULL
indicative	NULL
of	NULL
cytopathic	NULL
viral	NULL
effects	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
koilocytosislike	NULL
changes	NULL
and	NULL
nuclear	NULL
inclusion	NULL
bodies	NULL
,	NULL
are	NULL
observed	NULL
(	NULL
11	NULL
)	NULL
,	NULL
virus	NULL
replication	NULL
obviously	NULL
does	NULL
not	NULL
lead	NULL
to	NULL
cell	NULL
lysis	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
epithelial	NULL
cells	NULL
in	NULL
which	NULL
EBV	NULL
is	NULL
replicating	NULL
in	NULL
OHL	NULL
retain	NULL
their	NULL
ability	NULL
to	NULL
further	NULL
differentiate	NULL
,	NULL
since	NULL
dysplasia	NULL
is	NULL
usually	NULL
not	NULL
observed	NULL
in	NULL
this	NULL
lesion	NULL
.	NULL

Only	NULL
the	NULL
presence	NULL
of	NULL
parakeratosis	NULL
indicates	NULL
a	NULL
minor	NULL
impediment	NULL
in	NULL
the	NULL
normal	NULL
development	NULL
of	NULL
a	NULL
fully	NULL
mature	NULL
epithelium	NULL
.	NULL

It	NULL
seems	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
EBV	NULL
has	NULL
evolved	NULL
to	NULL
exploit	NULL
the	NULL
normal	NULL
process	NULL
of	NULL
epithelial	NULL
cell	NULL
differentiation	NULL
during	NULL
its	NULL
replicative	NULL
cycle	NULL
,	NULL
thereby	NULL
avoiding	NULL
significant	NULL
cytopathic	NULL
effects	NULL
or	NULL
associated	NULL
inflammatory	NULL
responses	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
behavior	NULL
of	NULL
EBV	NULL
in	NULL
OHL	NULL
resembles	NULL
that	NULL
of	NULL
human	NULL
papillomavirus	NULL
infections	NULL
in	NULL
which	NULL
viral	NULL
latency	NULL
is	NULL
maintained	NULL
in	NULL
the	NULL
basal	NULL
and	NULL
suprabasal	NULL
epithelial	NULL
layers	NULL
(	NULL
5	NULL
,	NULL
23	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
situ	NULL
hybridization	NULL
to	NULL
EBV	NULL
DNA	NULL
in	NULL
OHL	NULL
failed	NULL
to	NULL
detect	NULL
viral	NULL
DNA	NULL
in	NULL
the	NULL
lower	NULL
layers	NULL
of	NULL
the	NULL
lesion	NULL
.	NULL

This	NULL
finding	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
using	NULL
biotinylated	NULL
probes	NULL
(	NULL
2	NULL
,	NULL
8	NULL
)	NULL
.	NULL

The	NULL
highly	NULL
sensitive	NULL
in	NULL
situ	NULL
hybridization	NULL
technique	NULL
that	NULL
we	NULL
have	NULL
employed	NULL
in	NULL
this	NULL
study	NULL
uses	NULL
*Â°S-labeled	NULL
probes	NULL
and	NULL
is	NULL
able	NULL
to	NULL
detect	NULL
the	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
present	NULL
in	NULL
the	NULL
AW	NULL
Ramos	NULL
cell	NULL
line	NULL
(	NULL
14	NULL
)	NULL
.	NULL

It	NULL
may	NULL
be	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
EBV	NULL
is	NULL
not	NULL
latent	NULL
in	NULL
the	NULL
basal	NULL
layers	NULL
of	NULL
OHL	NULL
but	NULL
that	NULL
the	NULL
focal	NULL
areas	NULL
of	NULL
2872	NULL
YOUNG	NULL
ET	NULL
AL	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

Vor	NULL
.	NULL

65	NULL
,	NULL
1991	NULL
BZLF1	NULL
EXPRESSION	NULL
IN	NULL
ORAL	NULL
HAIRY	NULL
LEUKOPLAKIA	NULL
2873	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

(	NULL
a	NULL
)	NULL
Demonstration	NULL
of	NULL
EBV	NULL
DNA	NULL
in	NULL
an	NULL
OHL	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
using	NULL
a	NULL
**S-labeled	NULL
DNA	NULL
probe	NULL
(	NULL
3	NULL
days	NULL
of	NULL
exposure	NULL
;	NULL
hematoxylin	NULL
and	NULL
eosin	NULL
counterstaining	NULL
;	NULL
X200	NULL
)	NULL
.	NULL

(	NULL
b	NULL
)	NULL
Adjacent	NULL
section	NULL
of	NULL
the	NULL
same	NULL
sample	NULL
stained	NULL
with	NULL
MAb	NULL
BZ1	NULL
(	NULL
APAAP	NULL
technique	NULL
;	NULL
hematoxylin	NULL
counterstaining	NULL
;	NULL
X200	NULL
)	NULL
.	NULL

(	NULL
c	NULL
and	NULL
d	NULL
)	NULL
Double-labeling	NULL
immunohistology	NULL
and	NULL
in	NULL
situ	NULL
hybridization	NULL
of	NULL
an	NULL
OHL	NULL
biopsy	NULL
showing	NULL
a	NULL
layer	NULL
of	NULL
BZLF1-positive	NULL
cells	NULL
underneath	NULL
a	NULL
focus	NULL
of	NULL
viral	NULL
replication	NULL
(	NULL
c	NULL
;	NULL
3	NULL
days	NULL
of	NULL
exposure	NULL
;	NULL
hematoxylin	NULL
counterstaining	NULL
;	NULL
X100	NULL
)	NULL
,	NULL
which	NULL
display	NULL
a	NULL
weak	NULL
EBV-specific	NULL
signal	NULL
(	NULL
d	NULL
;	NULL
x400	NULL
)	NULL
.	NULL

FIG	NULL
.	NULL

5	NULL
.	NULL

Double	NULL
immunofluorescence	NULL
staining	NULL
of	NULL
an	NULL
OHL	NULL
section	NULL
for	NULL
VCA	NULL
(	NULL
a	NULL
;	NULL
X200	NULL
)	NULL
and	NULL
BZLF1	NULL
(	NULL
b	NULL
;	NULL
X200	NULL
)	NULL
,	NULL
revealing	NULL
a	NULL
layer	NULL
of	NULL
BZLF1l-positive	NULL
but	NULL
VCA-negative	NULL
cells	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

2874	NULL
YOUNG	NULL
ET	NULL
AL	NULL
.	NULL

EBV	NULL
replication	NULL
represent	NULL
regions	NULL
of	NULL
self-sustained	NULL
reinfec-tion	NULL
.	NULL

If	NULL
this	NULL
is	NULL
the	NULL
case	NULL
,	NULL
our	NULL
ideas	NULL
concerning	NULL
the	NULL
persistence	NULL
of	NULL
EBV	NULL
in	NULL
the	NULL
epithelial	NULL
compartment	NULL
may	NULL
have	NULL
to	NULL
be	NULL
revised	NULL
.	NULL

Indeed	NULL
,	NULL
other	NULL
recent	NULL
reports	NULL
have	NULL
questioned	NULL
the	NULL
role	NULL
of	NULL
epithelium	NULL
as	NULL
the	NULL
permanent	NULL
reservoir	NULL
of	NULL
EBV	NULL
infection	NULL
(	NULL
6	NULL
,	NULL
13	NULL
,	NULL
21	NULL
)	NULL
.	NULL

Further	NULL
studies	NULL
examining	NULL
the	NULL
pattern	NULL
of	NULL
EBV	NULL
latent	NULL
gene	NULL
expression	NULL
in	NULL
OHL	NULL
may	NULL
help	NULL
resolve	NULL
this	NULL
issue	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Cancer	NULL
Research	NULL
Campaign	NULL
,	NULL
London	NULL
,	NULL
United	NULL
Kingdom	NULL
,	NULL
and	NULL
by	NULL
NIH	NULL
grant	NULL
PO1	NULL
DEO7946	NULL
.	NULL

Support	NULL
for	NULL
G.N	NULL
.	NULL

was	NULL
provided	NULL
by	NULL
the	NULL
Deutsche	NULL
Forschungsgemein-schaft	NULL
.	NULL

We	NULL
are	NULL
indebted	NULL
to	NULL
J.	NULL
R.	NULL
Harris	NULL
and	NULL
A.	NULL
J.	NULL
Pinching	NULL
for	NULL
access	NULL
to	NULL
their	NULL
patients	NULL
,	NULL
to	NULL
M.	NULL
Birchall	NULL
for	NULL
collecting	NULL
biopsies	NULL
,	NULL
and	NULL
to	NULL
H.	NULL
Stein	NULL
(	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
kindly	NULL
providing	NULL
the	NULL
APAAP	NULL
complex	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Cordell	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
B.	NULL
Falini	NULL
,	NULL
W.	NULL
N.	NULL
Erber	NULL
,	NULL
A.	NULL
K.	NULL
Ghosh	NULL
,	NULL
Z.	NULL
Abdulaziz	NULL
,	NULL
S.	NULL
MacDonald	NULL
,	NULL
K.	NULL
A.	NULL
F.	NULL
Pulford	NULL
,	NULL
H.	NULL
Stein	NULL
,	NULL
and	NULL
D.	NULL
Y.	NULL
Mason	NULL
.	NULL

1984	NULL
.	NULL

Immunoenzymatic	NULL
labelling	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
using	NULL
immune	NULL
complexes	NULL
of	NULL
alkaline	NULL
phosphatase	NULL
and	NULL
monoclonal	NULL
anti-alkaline	NULL
phosphatase	NULL
(	NULL
APAAP	NULL
complexes	NULL
)	NULL
.	NULL

J.	NULL
Histochem	NULL
.	NULL

Cytochem	NULL
.	NULL

32:219-229	NULL
.	NULL

2	NULL
.	NULL

De	NULL
Souza	NULL
,	NULL
Y.	NULL
G.	NULL
,	NULL
D.	NULL
Greenspan	NULL
,	NULL
J.	NULL
R.	NULL
Felton	NULL
,	NULL
G.	NULL
A.	NULL
Hartzog	NULL
,	NULL
M.	NULL
Hammer	NULL
,	NULL
and	NULL
J.	NULL
S.	NULL
Greenspan	NULL
.	NULL

1989	NULL
.	NULL

Localization	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
DNA	NULL
in	NULL
the	NULL
epithelial	NULL
cells	NULL
of	NULL
oral	NULL
hairy	NULL
leukoplakia	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
on	NULL
tissue	NULL
sections	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

320:1559-1560	NULL
.	NULL

3	NULL
.	NULL

Farrell	NULL
,	NULL
P.	NULL
J.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
C.	NULL
M.	NULL
Rooney	NULL
,	NULL
and	NULL
T.	NULL
Kouzarides	NULL
.	NULL

1989	NULL
.	NULL

Epstein	NULL
Barr	NULL
virus	NULL
BZLF1l	NULL
transactivator	NULL
specifically	NULL
binds	NULL
to	NULL
a	NULL
consensus	NULL
AP-1	NULL
site	NULL
and	NULL
is	NULL
related	NULL
to	NULL
c-fos	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:127-132	NULL
.	NULL

4	NULL
.	NULL

Friedman-Kien	NULL
,	NULL
A.	NULL
E.	NULL
1986	NULL
.	NULL

Viral	NULL
origin	NULL
of	NULL
hairy	NULL
leukoplakia	NULL
.	NULL

Lancet	NULL
i1:694-695	NULL
.	NULL

5	NULL
.	NULL

Gilligan	NULL
,	NULL
K.	NULL
,	NULL
P.	NULL
Rajadurai	NULL
,	NULL
L.	NULL
Resnick	NULL
,	NULL
and	NULL
N.	NULL
Raab-Traub	NULL
.	NULL

1990	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
small	NULL
nuclear	NULL
RNAs	NULL
are	NULL
not	NULL
expressed	NULL
in	NULL
permissively	NULL
infected	NULL
cells	NULL
in	NULL
AIDS-associated	NULL
leukoplakia	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
$	NULL
7:8790-8794	NULL
.	NULL

6	NULL
.	NULL

Gratama	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
M.	NULL
A.	NULL
P.	NULL
Osterveer	NULL
,	NULL
F.	NULL
E.	NULL
Zwann	NULL
,	NULL
J.	NULL
Lepoutre	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
I.	NULL
Ernberg	NULL
.	NULL

1988	NULL
.	NULL

Eradication	NULL
of	NULL
Epstein	NULL
Barr	NULL
virus	NULL
by	NULL
allogeneic	NULL
bone	NULL
marrow	NULL
transplantation	NULL
:	NULL
implications	NULL
for	NULL
sites	NULL
of	NULL
viral	NULL
latency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8693-8696	NULL
.	NULL

7	NULL
.	NULL

Greenspan	NULL
,	NULL
D.	NULL
,	NULL
J.	NULL
S.	NULL
Greenspan	NULL
,	NULL
M.	NULL
Conart	NULL
,	NULL
V.	NULL
Petersen	NULL
,	NULL
S.	NULL
Silverman	NULL
,	NULL
and	NULL
Y.	NULL
de	NULL
Souza	NULL
.	NULL

1984	NULL
.	NULL

Oral	NULL
``	NULL
hairy	NULL
``	NULL
leukoplakia	NULL
in	NULL
male	NULL
homosexuals	NULL
:	NULL
evidence	NULL
of	NULL
association	NULL
with	NULL
both	NULL
papillomavirus	NULL
and	NULL
a	NULL
herpes-group	NULL
virus	NULL
.	NULL

Lancet	NULL
ii:831-834	NULL
.	NULL

8	NULL
.	NULL

Greenspan	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
D.	NULL
Greenspan	NULL
,	NULL
E.	NULL
Lennette	NULL
,	NULL
D.	NULL
I.	NULL
Abrams	NULL
,	NULL
M.	NULL
A.	NULL
Conart	NULL
,	NULL
V.	NULL
Petersen	NULL
,	NULL
and	NULL
U.	NULL
K.	NULL
Freese	NULL
.	NULL

1985	NULL
.	NULL

Replication	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
within	NULL
the	NULL
epithelial	NULL
cells	NULL
of	NULL
oral	NULL
``	NULL
hairy	NULL
``	NULL
leukoplakia	NULL
,	NULL
an	NULL
AIDS-associated	NULL
lesion	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

J.	NULL
Viror	NULL
.	NULL

313:1564-1571.	NULL
.	NULL

Kouzarides	NULL
,	NULL
T.	NULL
,	NULL
G.	NULL
Packham	NULL
,	NULL
A.	NULL
Cook	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
BZLF1	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
has	NULL
a	NULL
coiled-coil	NULL
dimerisation	NULL
domain	NULL
without	NULL
a	NULL
heptad	NULL
leucine	NULL
repeat	NULL
but	NULL
with	NULL
homology	NULL
to	NULL
the	NULL
C/EBP	NULL
leucine	NULL
zipper	NULL
.	NULL

Oncogene	NULL
6:195-204	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1990	NULL
.	NULL

In	NULL
vitro	NULL
transcriptional	NULL
activation	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
DNA-binding	NULL
specificity	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
Zta	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:2560-2568	NULL
.	NULL

Loning	NULL
,	NULL
T.	NULL
,	NULL
R.	NULL
P.	NULL
Henke	NULL
,	NULL
R.	NULL
Reichart	NULL
,	NULL
and	NULL
J.	NULL
Becker	NULL
.	NULL

1987	NULL
.	NULL

In	NULL
situ	NULL
hybridisation	NULL
to	NULL
detect	NULL
Epstein	NULL
Barr	NULL
virus	NULL
DNA	NULL
in	NULL
oral	NULL
tissues	NULL
of	NULL
HIV-infected	NULL
patients	NULL
.	NULL

Virchows	NULL
Archiv	NULL
.	NULL

A	NULL
412:127-133	NULL
.	NULL

Miller	NULL
,	NULL
G.	NULL
1990	NULL
.	NULL

The	NULL
switch	NULL
between	NULL
latency	NULL
and	NULL
replication	NULL
of	NULL
Epstein	NULL
Barr	NULL
virus	NULL
.	NULL

J.	NULL
Infect	NULL
.	NULL

Dis	NULL
.	NULL

161:833-844	NULL
.	NULL

Niedobitek	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Hamilton-Dutoit	NULL
,	NULL
H.	NULL
Herbst	NULL
,	NULL
T.	NULL
Finn	NULL
,	NULL
M.	NULL
Vetner	NULL
,	NULL
G.	NULL
Pallesen	NULL
,	NULL
and	NULL
H.	NULL
Stein	NULL
.	NULL

1989	NULL
.	NULL

Identification	NULL
of	NULL
Epstein	NULL
Barr	NULL
virus-infected	NULL
cells	NULL
in	NULL
tonsils	NULL
of	NULL
acute	NULL
infectious	NULL
mononucleosis	NULL
by	NULL
in	NULL
situ	NULL
hybridisation	NULL
.	NULL

Hum	NULL
.	NULL

Pathol	NULL
.	NULL

20:796-799	NULL
.	NULL

Niedobitek	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
H.	NULL
Herbst	NULL
.	NULL

Applications	NULL
of	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Int	NULL
.	NULL

Rev	NULL
.	NULL

Exp	NULL
.	NULL

Pathol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

Niedobitek	NULL
,	NULL
G.	NULL
,	NULL
R.	NULL
Lau	NULL
,	NULL
and	NULL
L.	NULL
S.	NULL
Young	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

Polack	NULL
,	NULL
A.	NULL
,	NULL
G.	NULL
Harti	NULL
,	NULL
U.	NULL
Zimber	NULL
,	NULL
U.	NULL
K.	NULL
Freese	NULL
,	NULL
G.	NULL
Laux	NULL
,	NULL
K.	NULL
Takaki	NULL
,	NULL
B.	NULL
Hohn	NULL
,	NULL
L.	NULL
Gissmann	NULL
,	NULL
and	NULL
G.	NULL
Bornkamm	NULL
.	NULL

1984	NULL
.	NULL

A	NULL
complete	NULL
set	NULL
of	NULL
overlapping	NULL
cosmid	NULL
clones	NULL
of	NULL
M-ABA	NULL
virus	NULL
derived	NULL
from	NULL
nasopharyngeal	NULL
carcinoma	NULL
and	NULL
its	NULL
similarity	NULL
to	NULL
other	NULL
Epstein	NULL
Barr	NULL
virus	NULL
isolates	NULL
.	NULL

Gene	NULL
27:279-288	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
D.	NULL
T.	NULL
Rowe	NULL
,	NULL
T.	NULL
Ragot	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
spliced	NULL
BZLF1	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
transac-tivates	NULL
an	NULL
early	NULL
EBV	NULL
promoter	NULL
and	NULL
induces	NULL
the	NULL
virus	NULL
productive	NULL
cycle	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:3109-3116	NULL
.	NULL

Rooney	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
N.	NULL
Taylor	NULL
,	NULL
J.	NULL
Countryman	NULL
,	NULL
H.	NULL
Jenson	NULL
,	NULL
J.	NULL
Kolman	NULL
,	NULL
and	NULL
G.	NULL
Miller	NULL
.	NULL

1988	NULL
.	NULL

Genome	NULL
rearrangements	NULL
activate	NULL
the	NULL
Epstein	NULL
Barr	NULL
virus	NULL
gene	NULL
whose	NULL
product	NULL
disrupts	NULL
latency	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:9801-9805	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
S.	NULL
Evans	NULL
,	NULL
L.	NULL
S.	NULL
Young	NULL
,	NULL
K.	NULL
Hennessy	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1987	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
to	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein	NULL
Barr	NULL
virus	NULL
reveal	NULL
heterogeneity	NULL
of	NULL
the	NULL
protein	NULL
and	NULL
inducible	NULL
expression	NULL
in	NULL
virus-transformed	NULL
cells	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

68:1575-1586	NULL
.	NULL

Rowe	NULL
,	NULL
M.	NULL
,	NULL
L.	NULL
S.	NULL
Young	NULL
,	NULL
K.	NULL
Cadwallader	NULL
,	NULL
L.	NULL
Petti	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1989	NULL
.	NULL

Distinction	NULL
between	NULL
Epstein-Barr	NULL
virus	NULL
type	NULL
A	NULL
(	NULL
EBNA	NULL
2A	NULL
)	NULL
and	NULL
type	NULL
B	NULL
(	NULL
EBNA	NULL
2B	NULL
)	NULL
isolates	NULL
extends	NULL
to	NULL
the	NULL
EBNA	NULL
3	NULL
family	NULL
of	NULL
nuclear	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

63:1031-1039	NULL
.	NULL

Yao	NULL
,	NULL
Q.-Y	NULL
.	NULL

,	NULL
P.	NULL
Ogan	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
M.	NULL
Wood	NULL
,	NULL
and	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
.	NULL

1989	NULL
.	NULL

Epstein	NULL
Barr	NULL
virus-infected	NULL
B	NULL
cells	NULL
persist	NULL
in	NULL
the	NULL
circulation	NULL
of	NULL
acyclovir-treated	NULL
virus	NULL
carriers	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
43:67-71	NULL
.	NULL

Young	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
C.	NULL
Alfieri	NULL
,	NULL
K.	NULL
Hennessy	NULL
,	NULL
H.	NULL
Evans	NULL
,	NULL
C.	NULL
O'Hara	NULL
,	NULL
C.	NULL
Anderson	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
R.	NULL
S.	NULL
Shapiro	NULL
,	NULL
A	NULL
.	NULL

B.	NULL
Rickinson	NULL
,	NULL
E.	NULL
Kieff	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Cohen	NULL
.	NULL

1989	NULL
.	NULL

Expression	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
transformation	NULL
associated	NULL
genes	NULL
in	NULL
tissues	NULL
from	NULL
patients	NULL
with	NULL
EBV	NULL
lym-phoproliferative	NULL
disease	NULL
.	NULL

N.	NULL
Engl	NULL
.	NULL

J.	NULL
Med	NULL
.	NULL

321:1080-1085	NULL
.	NULL

Young	NULL
,	NULL
L.	NULL
S.	NULL
,	NULL
and	NULL
J.	NULL
W.	NULL
Sixbey	NULL
.	NULL

1988	NULL
.	NULL

Epstein	NULL
Barr	NULL
virus	NULL
and	NULL
epithelial	NULL
cells	NULL
:	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
the	NULL
virus	NULL
in	NULL
the	NULL
development	NULL
of	NULL
cervical	NULL
carcinoma	NULL
.	NULL

Cancer	NULL
Surv	NULL
.	NULL

7:507-518	NULL
.	NULL

